CADTH Canadian drug expert committee recommendation (final) : indication : treatment of adult patients with moderate-to severe plaque psoriasis who are candidates for systemic therapy. Certolizumab pegol (Cimzia -- UCB Canada Inc.)

CADTH Canadian drug expert committee recommendation (final) indication : treatment of adult patients with moderate-to severe plaque psoriasis who are candidates for systemic therapy. Certolizumab pegol (Cimzia -- UCB Canada Inc.)

Mostrar otras versiones (5)
Detalles Bibliográficos
Autor principal: Canadian Agency for Drugs and Technologies in Health (author)
Autor Corporativo: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health 2019.
Materias:
Economic development projects > Cost effectiveness.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820284006719

Ejemplares similares

Ejemplares similares